Global Anti-Neoplastic Therapy Market Size, Status and Forecast 2021-2027

Global Anti-Neoplastic Therapy Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Neoplastic Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapeutic Agents
1.2.3 Immunotherapeutic Agents
1.2.4 Personalized Medicine
1.3 Market by Application
1.3.1 Global Anti-Neoplastic Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Rehabilitation Centers
1.3.5 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-Neoplastic Therapy Market Perspective (2016-2027)
2.2 Anti-Neoplastic Therapy Growth Trends by Regions
2.2.1 Anti-Neoplastic Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-Neoplastic Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Anti-Neoplastic Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Anti-Neoplastic Therapy Industry Dynamic
2.3.1 Anti-Neoplastic Therapy Market Trends
2.3.2 Anti-Neoplastic Therapy Market Drivers
2.3.3 Anti-Neoplastic Therapy Market Challenges
2.3.4 Anti-Neoplastic Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Neoplastic Therapy Players by Revenue
3.1.1 Global Top Anti-Neoplastic Therapy Players by Revenue (2016-2021)
3.1.2 Global Anti-Neoplastic Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Anti-Neoplastic Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-Neoplastic Therapy Revenue
3.4 Global Anti-Neoplastic Therapy Market Concentration Ratio
3.4.1 Global Anti-Neoplastic Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Neoplastic Therapy Revenue in 2020
3.5 Anti-Neoplastic Therapy Key Players Head office and Area Served
3.6 Key Players Anti-Neoplastic Therapy Product Solution and Service
3.7 Date of Enter into Anti-Neoplastic Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Neoplastic Therapy Breakdown Data by Type
4.1 Global Anti-Neoplastic Therapy Historic Market Size by Type (2016-2021)
4.2 Global Anti-Neoplastic Therapy Forecasted Market Size by Type (2022-2027)
5 Anti-Neoplastic Therapy Breakdown Data by Application
5.1 Global Anti-Neoplastic Therapy Historic Market Size by Application (2016-2021)
5.2 Global Anti-Neoplastic Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-Neoplastic Therapy Market Size (2016-2027)
6.2 North America Anti-Neoplastic Therapy Market Size by Type
6.2.1 North America Anti-Neoplastic Therapy Market Size by Type (2016-2021)
6.2.2 North America Anti-Neoplastic Therapy Market Size by Type (2022-2027)
6.2.3 North America Anti-Neoplastic Therapy Market Size by Type (2016-2027)
6.3 North America Anti-Neoplastic Therapy Market Size by Application
6.3.1 North America Anti-Neoplastic Therapy Market Size by Application (2016-2021)
6.3.2 North America Anti-Neoplastic Therapy Market Size by Application (2022-2027)
6.3.3 North America Anti-Neoplastic Therapy Market Size by Application (2016-2027)
6.4 North America Anti-Neoplastic Therapy Market Size by Country
6.4.1 North America Anti-Neoplastic Therapy Market Size by Country (2016-2021)
6.4.2 North America Anti-Neoplastic Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-Neoplastic Therapy Market Size (2016-2027)
7.2 Europe Anti-Neoplastic Therapy Market Size by Type
7.2.1 Europe Anti-Neoplastic Therapy Market Size by Type (2016-2021)
7.2.2 Europe Anti-Neoplastic Therapy Market Size by Type (2022-2027)
7.2.3 Europe Anti-Neoplastic Therapy Market Size by Type (2016-2027)
7.3 Europe Anti-Neoplastic Therapy Market Size by Application
7.3.1 Europe Anti-Neoplastic Therapy Market Size by Application (2016-2021)
7.3.2 Europe Anti-Neoplastic Therapy Market Size by Application (2022-2027)
7.3.3 Europe Anti-Neoplastic Therapy Market Size by Application (2016-2027)
7.4 Europe Anti-Neoplastic Therapy Market Size by Country
7.4.1 Europe Anti-Neoplastic Therapy Market Size by Country (2016-2021)
7.4.2 Europe Anti-Neoplastic Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-Neoplastic Therapy Market Size (2016-2027)
8.2 Asia-Pacific Anti-Neoplastic Therapy Market Size by Type
8.2.1 Asia-Pacific Anti-Neoplastic Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-Neoplastic Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-Neoplastic Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-Neoplastic Therapy Market Size by Application
8.3.1 Asia-Pacific Anti-Neoplastic Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-Neoplastic Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-Neoplastic Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-Neoplastic Therapy Market Size by Region
8.4.1 Asia-Pacific Anti-Neoplastic Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-Neoplastic Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-Neoplastic Therapy Market Size (2016-2027)
9.2 Latin America Anti-Neoplastic Therapy Market Size by Type
9.2.1 Latin America Anti-Neoplastic Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Anti-Neoplastic Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Anti-Neoplastic Therapy Market Size by Type (2016-2027)
9.3 Latin America Anti-Neoplastic Therapy Market Size by Application
9.3.1 Latin America Anti-Neoplastic Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Anti-Neoplastic Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Anti-Neoplastic Therapy Market Size by Application (2016-2027)
9.4 Latin America Anti-Neoplastic Therapy Market Size by Country
9.4.1 Latin America Anti-Neoplastic Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Anti-Neoplastic Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Neoplastic Therapy Market Size (2016-2027)
10.2 Middle East & Africa Anti-Neoplastic Therapy Market Size by Type
10.2.1 Middle East & Africa Anti-Neoplastic Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-Neoplastic Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-Neoplastic Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-Neoplastic Therapy Market Size by Application
10.3.1 Middle East & Africa Anti-Neoplastic Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-Neoplastic Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-Neoplastic Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-Neoplastic Therapy Market Size by Country
10.4.1 Middle East & Africa Anti-Neoplastic Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-Neoplastic Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Anti-Neoplastic Therapy Introduction
11.1.4 Amgen Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.1.5 Amgen Inc. Recent Development
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Details
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Anti-Neoplastic Therapy Introduction
11.2.4 AstraZeneca plc Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.2.5 AstraZeneca plc Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Anti-Neoplastic Therapy Introduction
11.3.4 Bayer AG Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.3.5 Bayer AG Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Anti-Neoplastic Therapy Introduction
11.4.4 Johnson & Johnson Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Details
11.5.2 Merck & Co., Inc. Business Overview
11.5.3 Merck & Co., Inc. Anti-Neoplastic Therapy Introduction
11.5.4 Merck & Co., Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.5.5 Merck & Co., Inc. Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Details
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Anti-Neoplastic Therapy Introduction
11.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.6.5 Pfizer Inc. Recent Development
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Company Details
11.7.2 F. Hoffmann-La Roche Ltd. Business Overview
11.7.3 F. Hoffmann-La Roche Ltd. Anti-Neoplastic Therapy Introduction
11.7.4 F. Hoffmann-La Roche Ltd. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.7.5 F. Hoffmann-La Roche Ltd. Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Anti-Neoplastic Therapy Introduction
11.8.4 Eli Lilly and Company Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.8.5 Eli Lilly and Company Recent Development
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Details
11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.9.3 Teva Pharmaceutical Industries Ltd. Anti-Neoplastic Therapy Introduction
11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Details
11.10.2 Boehringer Ingelheim Business Overview
11.10.3 Boehringer Ingelheim Anti-Neoplastic Therapy Introduction
11.10.4 Boehringer Ingelheim Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.10.5 Boehringer Ingelheim Recent Development
11.11 Aspen Pharmacare Holdings Limited
11.11.1 Aspen Pharmacare Holdings Limited Company Details
11.11.2 Aspen Pharmacare Holdings Limited Business Overview
11.11.3 Aspen Pharmacare Holdings Limited Anti-Neoplastic Therapy Introduction
11.11.4 Aspen Pharmacare Holdings Limited Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.11.5 Aspen Pharmacare Holdings Limited Recent Development
11.12 AbbVie Inc.
11.12.1 AbbVie Inc. Company Details
11.12.2 AbbVie Inc. Business Overview
11.12.3 AbbVie Inc. Anti-Neoplastic Therapy Introduction
11.12.4 AbbVie Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021)
11.12.5 AbbVie Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Anti-Neoplastic Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapeutic Agents
Table 3. Key Players of Immunotherapeutic Agents
Table 4. Key Players of Personalized Medicine
Table 5. Global Anti-Neoplastic Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-Neoplastic Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anti-Neoplastic Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Anti-Neoplastic Therapy Market Share by Regions (2016-2021)
Table 9. Global Anti-Neoplastic Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Anti-Neoplastic Therapy Market Share by Regions (2022-2027)
Table 11. Anti-Neoplastic Therapy Market Trends
Table 12. Anti-Neoplastic Therapy Market Drivers
Table 13. Anti-Neoplastic Therapy Market Challenges
Table 14. Anti-Neoplastic Therapy Market Restraints
Table 15. Global Anti-Neoplastic Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Anti-Neoplastic Therapy Market Share by Players (2016-2021)
Table 17. Global Top Anti-Neoplastic Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Therapy as of 2020)
Table 18. Ranking of Global Top Anti-Neoplastic Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Anti-Neoplastic Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anti-Neoplastic Therapy Product Solution and Service
Table 22. Date of Enter into Anti-Neoplastic Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-Neoplastic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Anti-Neoplastic Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Anti-Neoplastic Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Anti-Neoplastic Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Anti-Neoplastic Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Anti-Neoplastic Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Anti-Neoplastic Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Anti-Neoplastic Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Anti-Neoplastic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Anti-Neoplastic Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Anti-Neoplastic Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Anti-Neoplastic Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Anti-Neoplastic Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Anti-Neoplastic Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Anti-Neoplastic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Anti-Neoplastic Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Anti-Neoplastic Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Anti-Neoplastic Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Anti-Neoplastic Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Anti-Neoplastic Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Anti-Neoplastic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Anti-Neoplastic Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anti-Neoplastic Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anti-Neoplastic Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti-Neoplastic Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Anti-Neoplastic Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Anti-Neoplastic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Anti-Neoplastic Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Anti-Neoplastic Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Anti-Neoplastic Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Anti-Neoplastic Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Anti-Neoplastic Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Anti-Neoplastic Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Anti-Neoplastic Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anti-Neoplastic Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anti-Neoplastic Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti-Neoplastic Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Anti-Neoplastic Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Amgen Inc. Company Details
Table 63. Amgen Inc. Business Overview
Table 64. Amgen Inc. Anti-Neoplastic Therapy Product
Table 65. Amgen Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 66. Amgen Inc. Recent Development
Table 67. AstraZeneca plc Company Details
Table 68. AstraZeneca plc Business Overview
Table 69. AstraZeneca plc Anti-Neoplastic Therapy Product
Table 70. AstraZeneca plc Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca plc Recent Development
Table 72. Bayer AG Company Details
Table 73. Bayer AG Business Overview
Table 74. Bayer AG Anti-Neoplastic Therapy Product
Table 75. Bayer AG Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 76. Bayer AG Recent Development
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Anti-Neoplastic Therapy Product
Table 80. Johnson & Johnson Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. Merck & Co., Inc. Company Details
Table 83. Merck & Co., Inc. Business Overview
Table 84. Merck & Co., Inc. Anti-Neoplastic Therapy Product
Table 85. Merck & Co., Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 86. Merck & Co., Inc. Recent Development
Table 87. Pfizer Inc. Company Details
Table 88. Pfizer Inc. Business Overview
Table 89. Pfizer Inc. Anti-Neoplastic Therapy Product
Table 90. Pfizer Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 91. Pfizer Inc. Recent Development
Table 92. F. Hoffmann-La Roche Ltd. Company Details
Table 93. F. Hoffmann-La Roche Ltd. Business Overview
Table 94. F. Hoffmann-La Roche Ltd. Anti-Neoplastic Therapy Product
Table 95. F. Hoffmann-La Roche Ltd. Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 96. F. Hoffmann-La Roche Ltd. Recent Development
Table 97. Eli Lilly and Company Company Details
Table 98. Eli Lilly and Company Business Overview
Table 99. Eli Lilly and Company Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 100. Eli Lilly and Company Recent Development
Table 101. Teva Pharmaceutical Industries Ltd. Company Details
Table 102. Teva Pharmaceutical Industries Ltd. Business Overview
Table 103. Teva Pharmaceutical Industries Ltd. Anti-Neoplastic Therapy Product
Table 104. Teva Pharmaceutical Industries Ltd. Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 105. Teva Pharmaceutical Industries Ltd. Recent Development
Table 106. Boehringer Ingelheim Company Details
Table 107. Boehringer Ingelheim Business Overview
Table 108. Boehringer Ingelheim Anti-Neoplastic Therapy Product
Table 109. Boehringer Ingelheim Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 110. Boehringer Ingelheim Recent Development
Table 111. Aspen Pharmacare Holdings Limited Company Details
Table 112. Aspen Pharmacare Holdings Limited Business Overview
Table 113. Aspen Pharmacare Holdings Limited Anti-Neoplastic Therapy Product
Table 114. Aspen Pharmacare Holdings Limited Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 115. Aspen Pharmacare Holdings Limited Recent Development
Table 116. AbbVie Inc. Company Details
Table 117. AbbVie Inc. Business Overview
Table 118. AbbVie Inc. Anti-Neoplastic Therapy Product
Table 119. AbbVie Inc. Revenue in Anti-Neoplastic Therapy Business (2016-2021) & (US$ Million)
Table 120. AbbVie Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Neoplastic Therapy Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapeutic Agents Features
Figure 3. Immunotherapeutic Agents Features
Figure 4. Personalized Medicine Features
Figure 5. Global Anti-Neoplastic Therapy Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Cancer Rehabilitation Centers Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Anti-Neoplastic Therapy Report Years Considered
Figure 11. Global Anti-Neoplastic Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Anti-Neoplastic Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anti-Neoplastic Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Anti-Neoplastic Therapy Market Share by Regions (2022-2027)
Figure 15. Global Anti-Neoplastic Therapy Market Share by Players in 2020
Figure 16. Global Top Anti-Neoplastic Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Anti-Neoplastic Therapy Revenue in 2020
Figure 18. Global Anti-Neoplastic Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Anti-Neoplastic Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Anti-Neoplastic Therapy Market Share by Type (2016-2027)
Figure 22. North America Anti-Neoplastic Therapy Market Share by Application (2016-2027)
Figure 23. North America Anti-Neoplastic Therapy Market Share by Country (2016-2027)
Figure 24. United States Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anti-Neoplastic Therapy Market Share by Type (2016-2027)
Figure 28. Europe Anti-Neoplastic Therapy Market Share by Application (2016-2027)
Figure 29. Europe Anti-Neoplastic Therapy Market Share by Country (2016-2027)
Figure 30. Germany Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anti-Neoplastic Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Anti-Neoplastic Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Anti-Neoplastic Therapy Market Share by Region (2016-2027)
Figure 40. China Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anti-Neoplastic Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Anti-Neoplastic Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Anti-Neoplastic Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anti-Neoplastic Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Anti-Neoplastic Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Anti-Neoplastic Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Anti-Neoplastic Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Amgen Inc. Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 60. AstraZeneca plc Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 61. Bayer AG Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 63. Merck & Co., Inc. Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 64. Pfizer Inc. Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 65. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 67. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 68. Boehringer Ingelheim Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 69. Aspen Pharmacare Holdings Limited Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 70. AbbVie Inc. Revenue Growth Rate in Anti-Neoplastic Therapy Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs